{
  "id": "huntingtons-disease",
  "title": "Huntington's Disease",
  "version": "1.1",
  "icd10": [
    "** G10 (Huntington disease)",
    "F02.80 (Dementia in HD without behavioral disturbance)",
    "F02.81 (Dementia in HD with behavioral disturbance)"
  ],
  "scope": "** Diagnosis confirmation via genetic testing, chorea management, psychiatric symptom treatment, cognitive decline management, dysphagia assessment, genetic counseling, and end-of-life planning. Focuses primarily on outpatient management. Excludes Huntington disease-like syndromes (HDL1-4) and other chorea etiologies.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "Huntington gene test (HTT CAG repeat) (CPT 81401)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Definitive diagnosis; CAG repeat expansion",
          "target": "â‰¥36 CAG repeats diagnostic (40+ fully penetrant)"
        },
        {
          "item": "CBC (CPT 85025)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline; anemia contributes to fatigue; infection screen",
          "target": "Normal"
        },
        {
          "item": "BMP (CPT 80048)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Electrolytes; renal function for medication dosing",
          "target": "Normal"
        },
        {
          "item": "Hepatic panel (LFTs) (CPT 80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline before tetrabenazine/deutetrabenazine; valproate if used",
          "target": "Normal"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hypothyroidism can mimic apathy and cognitive slowing",
          "target": "Normal"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency can worsen cognitive and psychiatric symptoms",
          "target": ">300 pg/mL"
        },
        {
          "item": "Vitamin D, 25-hydroxy (CPT 82306)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency common; contributes to falls and bone health",
          "target": ">30 ng/mL"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "Iron studies (CPT 83540), ferritin (CPT 82728)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Neurodegeneration with brain iron accumulation if HD-negative",
          "target": "Normal"
        },
        {
          "item": "Ceruloplasmin (CPT 82390), serum copper (CPT 82525)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Wilson's disease if younger onset, HD gene-negative",
          "target": "Normal"
        },
        {
          "item": "ACTN3 gene test (CPT 81479)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Research; may modify age of onset",
          "target": "Research use"
        },
        {
          "item": "Acanthocyte screen (peripheral smear) (CPT 85060)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Chorea-acanthocytosis if HD gene-negative",
          "target": "No acanthocytes"
        },
        {
          "item": "Lipid panel (CPT 80061)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Cardiovascular risk; weight loss monitoring",
          "target": "Normal"
        },
        {
          "item": "Prealbumin (CPT 84134), albumin (CPT 82040)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Nutritional status assessment in advanced disease",
          "target": "Normal"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "Genetic testing for HDL syndromes (PRNP, JPH3, TBP, ATN1) (CPT 81479)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "HD-like phenotype with negative HTT test",
          "target": "Identifies HD-like syndrome"
        },
        {
          "item": "CSF biomarkers (neurofilament light chain) (CPT 83519)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Disease progression monitoring; research",
          "target": "Elevated in active disease"
        },
        {
          "item": "Kynurenine pathway metabolites (CPT 82542)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Research; therapeutic target assessment",
          "target": "Research use"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI Brain without contrast (CPT 70551)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis",
          "target": "Caudate atrophy; lateral ventricle enlargement (\"boxcar\" ventricles)",
          "contraindications": "MRI-incompatible devices"
        }
      ],
      "Extended": [
        {
          "item": "MRI Brain volumetric (CPT 70553)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline and annually for progression",
          "target": "Quantify caudate and striatal volume loss",
          "contraindications": "MRI contraindications"
        },
        {
          "item": "Swallowing evaluation (VFSS or FEES) (CPT 74230/92612)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis and with dysphagia symptoms",
          "target": "Identify aspiration risk; guide diet modification",
          "contraindications": "None"
        },
        {
          "item": "ECG (CPT 93000)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline before tetrabenazine/deutetrabenazine",
          "target": "QTc <450 ms",
          "contraindications": "None"
        },
        {
          "item": "Polysomnography (CPT 95810)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Sleep disturbance evaluation",
          "target": "Rule out sleep apnea; assess sleep architecture",
          "contraindications": "None"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "PET imaging (FDG or specific tracers) (CPT 78816)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Research; atypical presentation",
          "target": "Striatal hypometabolism",
          "contraindications": "None"
        },
        {
          "item": "Neuropsychological testing battery (CPT 96132)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis and annually",
          "target": "Baseline cognitive profile; monitor decline",
          "contraindications": "None"
        },
        {
          "item": "Genetic modifier testing (research) (CPT 81479)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Prognosis; clinical trials",
          "target": "Identifies modifiers of age of onset",
          "contraindications": "None"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Lorazepam",
          "route": "IV/PO",
          "indication": "Severe chorea causing injury or exhaustion",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg TID",
                "orderSentence": "Lorazepam 0.5 mg IV/PO TID"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Lorazepam 1 mg IV/PO TID"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Lorazepam 2 mg IV/PO TID"
              }
            ],
            "route": "IV/PO",
            "instructions": "0.5-2 mg IV/PO q4-6h PRN; short-term use only",
            "orderSentence": "Lorazepam 0.5 mg IV/PO TID"
          },
          "contraindications": "Respiratory depression; acute narrow-angle glaucoma",
          "monitoring": "Respiratory status, sedation",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Haloperidol",
          "route": "IV/IM",
          "indication": "Severe psychosis with agitation; acute behavioral emergency",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg BID",
                "orderSentence": "Haloperidol 0.5 mg IM BID"
              },
              {
                "text": "1 mg BID",
                "orderSentence": "Haloperidol 1 mg IM BID"
              },
              {
                "text": "2 mg BID",
                "orderSentence": "Haloperidol 2 mg IM BID"
              },
              {
                "text": "5 mg q4h PRN",
                "orderSentence": "Haloperidol 5 mg IM q4h PRN"
              }
            ],
            "route": "IM",
            "instructions": "2-5 mg IM; may repeat q4-6h; max 20 mg/day; transition to oral",
            "orderSentence": "Haloperidol 0.5 mg IM BID"
          },
          "contraindications": "QTc prolongation; history of NMS; worsens dystonia",
          "monitoring": "ECG, EPS, sedation",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Olanzapine",
          "route": "IM/PO",
          "indication": "Acute agitation with psychosis; alternative to haloperidol",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg daily",
                "orderSentence": "Olanzapine 2.5 mg IM daily"
              },
              {
                "text": "5 mg daily",
                "orderSentence": "Olanzapine 5 mg IM daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Olanzapine 10 mg IM daily"
              }
            ],
            "route": "IM",
            "instructions": "5-10 mg IM; may repeat in 2 hours; max 30 mg/day",
            "orderSentence": "Olanzapine 2.5 mg IM daily"
          },
          "contraindications": "Concurrent benzodiazepines (caution); diabetes",
          "monitoring": "Glucose, sedation, EPS",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "IV fluids",
          "route": "IV",
          "indication": "Dehydration from dysphagia or decreased oral intake",
          "dosing": {
            "doseOptions": [
              {
                "text": "NS at 75 mL/hr",
                "orderSentence": "IV fluids NS at 75 mL/hr IV"
              }
            ],
            "route": "IV",
            "instructions": "NS at 75-125 mL/hr; correct dehydration; transition to oral when safe",
            "orderSentence": "IV fluids NS at 75 mL/hr IV"
          },
          "contraindications": "Fluid overload",
          "monitoring": "I/O, electrolytes",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Thiamine",
          "route": "IV",
          "indication": "Nutritional deficiency; altered mental status",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg daily",
                "orderSentence": "Thiamine 100 mg IV daily"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Thiamine 100 mg IV daily"
              },
              {
                "text": "500 mg TID",
                "orderSentence": "Thiamine 500 mg IV TID"
              }
            ],
            "route": "IV",
            "instructions": "100 mg IV daily x 3-5 days; then oral",
            "orderSentence": "Thiamine 100 mg IV daily"
          },
          "contraindications": "None",
          "monitoring": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Symptomatic Treatments - Chorea": [
        {
          "item": "Tetrabenazine (Xenazine)",
          "route": "PO",
          "indication": "FDA-approved for HD chorea; first-line",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg daily",
                "orderSentence": "Tetrabenazine 12.5 mg PO daily"
              },
              {
                "text": "12.5 mg BID",
                "orderSentence": "Tetrabenazine 12.5 mg PO BID"
              },
              {
                "text": "25 mg BID",
                "orderSentence": "Tetrabenazine 25 mg PO BID"
              },
              {
                "text": "25 mg TID",
                "orderSentence": "Tetrabenazine 25 mg PO TID"
              }
            ],
            "route": "PO",
            "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 100 mg/day (25 mg per dose); CYP2D6 testing recommended",
            "orderSentence": "Tetrabenazine 12.5 mg PO daily"
          },
          "contraindications": "Active suicidality; untreated depression; concurrent MAOIs; hepatic impairment",
          "monitoring": "Depression (PHQ-9 monthly), akathisia, parkinsonism, QTc",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Deutetrabenazine (Austedo)",
          "route": "PO",
          "indication": "FDA-approved for HD chorea; better tolerability than tetrabenazine",
          "dosing": {
            "doseOptions": [
              {
                "text": "6 mg BID",
                "orderSentence": "Deutetrabenazine 6 mg PO BID"
              },
              {
                "text": "9 mg BID",
                "orderSentence": "Deutetrabenazine 9 mg PO BID"
              },
              {
                "text": "12 mg BID",
                "orderSentence": "Deutetrabenazine 12 mg PO BID"
              },
              {
                "text": "18 mg BID",
                "orderSentence": "Deutetrabenazine 18 mg PO BID"
              },
              {
                "text": "24 mg BID",
                "orderSentence": "Deutetrabenazine 24 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 6 mg daily; increase by 6 mg/wk; max 48 mg/day (24 mg per dose)",
            "orderSentence": "Deutetrabenazine 6 mg PO BID"
          },
          "contraindications": "Active suicidality; untreated depression; concurrent MAOIs; hepatic impairment",
          "monitoring": "Depression (PHQ-9 monthly), akathisia, parkinsonism, QTc",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Valbenazine (Ingrezza)",
          "route": "PO",
          "indication": "Off-label for HD chorea; once daily dosing",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg daily",
                "orderSentence": "Valbenazine 40 mg PO daily"
              },
              {
                "text": "60 mg daily",
                "orderSentence": "Valbenazine 60 mg PO daily"
              },
              {
                "text": "80 mg daily",
                "orderSentence": "Valbenazine 80 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 40 mg daily; may increase to 80 mg after 1 week",
            "orderSentence": "Valbenazine 40 mg PO daily"
          },
          "contraindications": "Severe hepatic impairment; concurrent MAOIs; congenital long QT",
          "monitoring": "Depression, akathisia, QTc prolongation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Risperidone",
          "route": "PO",
          "indication": "Chorea with psychosis; antipsychotic with motor benefit",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25 mg daily",
                "orderSentence": "Risperidone 0.25 mg PO daily"
              },
              {
                "text": "0.5 mg daily",
                "orderSentence": "Risperidone 0.5 mg PO daily"
              },
              {
                "text": "1 mg daily",
                "orderSentence": "Risperidone 1 mg PO daily"
              },
              {
                "text": "2 mg daily",
                "orderSentence": "Risperidone 2 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.5 mg daily; titrate by 0.5 mg q1wk; max 6 mg/day",
            "orderSentence": "Risperidone 0.25 mg PO daily"
          },
          "contraindications": "QTc prolongation; history of NMS",
          "monitoring": "EPS, metabolic panel, prolactin",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Olanzapine",
          "route": "PO",
          "indication": "Chorea with weight loss; promotes weight gain",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg daily",
                "orderSentence": "Olanzapine 2.5 mg PO daily"
              },
              {
                "text": "5 mg daily",
                "orderSentence": "Olanzapine 5 mg PO daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Olanzapine 10 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 2.5-5 mg qHS; titrate to effect; typical 5-15 mg/day",
            "orderSentence": "Olanzapine 2.5 mg PO daily"
          },
          "contraindications": "Diabetes; significant metabolic risk",
          "monitoring": "Weight, glucose, lipids",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clonazepam",
          "route": "PO",
          "indication": "Adjunct for chorea; also helps myoclonus and anxiety",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25 mg BID",
                "orderSentence": "Clonazepam 0.25 mg PO BID"
              },
              {
                "text": "0.5 mg BID",
                "orderSentence": "Clonazepam 0.5 mg PO BID"
              },
              {
                "text": "1 mg BID",
                "orderSentence": "Clonazepam 1 mg PO BID"
              },
              {
                "text": "2 mg BID",
                "orderSentence": "Clonazepam 2 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.25 mg BID; titrate slowly; max 4 mg/day",
            "orderSentence": "Clonazepam 0.25 mg PO BID"
          },
          "contraindications": "Severe respiratory disease; falls risk",
          "monitoring": "Sedation, falls, cognitive effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amantadine",
          "route": "PO",
          "indication": "Mild chorea; may help fatigue",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg daily",
                "orderSentence": "Amantadine 100 mg PO daily"
              },
              {
                "text": "100 mg BID",
                "orderSentence": "Amantadine 100 mg PO BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Amantadine 200 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg daily; titrate to 100 mg TID; max 400 mg/day",
            "orderSentence": "Amantadine 100 mg PO daily"
          },
          "contraindications": "End-stage renal disease; seizure history",
          "monitoring": "Livedo reticularis, hallucinations, edema",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments - Psychiatric": [
        {
          "item": "Sertraline",
          "route": "PO",
          "indication": "Depression; anxiety; irritability",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Sertraline 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; titrate by 25-50 mg q1-2wk; max 200 mg/day",
            "orderSentence": "Sertraline 25 mg PO"
          },
          "contraindications": "MAOIs within 14 days",
          "monitoring": "Suicidality, serotonin syndrome",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Citalopram",
          "route": "PO",
          "indication": "Depression; anxiety; good tolerability",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg",
                "orderSentence": "Citalopram 10 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 10 mg daily; max 20 mg/day due to QTc risk",
            "orderSentence": "Citalopram 10 mg PO"
          },
          "contraindications": "QTc >500 ms; concurrent QT-prolonging drugs",
          "monitoring": "QTc if risk factors",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Escitalopram",
          "route": "PO",
          "indication": "Depression; anxiety; similar to citalopram",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Escitalopram 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5-10 mg daily; max 20 mg/day",
            "orderSentence": "Escitalopram 5 mg PO"
          },
          "contraindications": "QTc >500 ms; concurrent QT-prolonging drugs",
          "monitoring": "QTc if risk factors",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Venlafaxine XR",
          "route": "PO",
          "indication": "Depression with fatigue; dual mechanism",
          "dosing": {
            "doseOptions": [
              {
                "text": "37.5 mg daily",
                "orderSentence": "Venlafaxine Xr 37.5 mg PO daily"
              },
              {
                "text": "75 mg daily",
                "orderSentence": "Venlafaxine Xr 75 mg PO daily"
              },
              {
                "text": "150 mg daily",
                "orderSentence": "Venlafaxine Xr 150 mg PO daily"
              },
              {
                "text": "225 mg daily",
                "orderSentence": "Venlafaxine Xr 225 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 37.5 mg daily; titrate q1wk; max 225 mg/day",
            "orderSentence": "Venlafaxine Xr 37.5 mg PO daily"
          },
          "contraindications": "Uncontrolled hypertension",
          "monitoring": "BP at higher doses",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mirtazapine",
          "route": "PO",
          "indication": "Depression with insomnia and weight loss; promotes appetite",
          "dosing": {
            "doseOptions": [
              {
                "text": "7.5 mg QHS",
                "orderSentence": "Mirtazapine 7.5 mg PO QHS"
              },
              {
                "text": "15 mg QHS",
                "orderSentence": "Mirtazapine 15 mg PO QHS"
              },
              {
                "text": "30 mg QHS",
                "orderSentence": "Mirtazapine 30 mg PO QHS"
              },
              {
                "text": "45 mg QHS",
                "orderSentence": "Mirtazapine 45 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 7.5-15 mg qHS; titrate q1-2wk; max 45 mg",
            "orderSentence": "Mirtazapine 7.5 mg PO QHS"
          },
          "contraindications": "None significant",
          "monitoring": "Weight, sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Quetiapine",
          "route": "PO",
          "indication": "Psychosis; irritability; insomnia; less EPS than other antipsychotics",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg QHS",
                "orderSentence": "Quetiapine 12.5 mg PO QHS"
              },
              {
                "text": "25 mg QHS",
                "orderSentence": "Quetiapine 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Quetiapine 50 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Quetiapine 100 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg qHS; titrate by 25-50 mg q3d; typical 150-400 mg/day",
            "orderSentence": "Quetiapine 12.5 mg PO QHS"
          },
          "contraindications": "Uncontrolled diabetes",
          "monitoring": "Glucose, lipids, QTc",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Aripiprazole",
          "route": "PO",
          "indication": "Psychosis; irritability; weight-neutral",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg daily",
                "orderSentence": "Aripiprazole 2 mg PO daily"
              },
              {
                "text": "5 mg daily",
                "orderSentence": "Aripiprazole 5 mg PO daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Aripiprazole 10 mg PO daily"
              },
              {
                "text": "15 mg daily",
                "orderSentence": "Aripiprazole 15 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 2-5 mg daily; titrate by 5 mg q1wk; max 30 mg/day",
            "orderSentence": "Aripiprazole 2 mg PO daily"
          },
          "contraindications": "None significant",
          "monitoring": "Akathisia, EPS",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lamotrigine",
          "route": "PO",
          "indication": "Mood stabilization; irritability",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg daily",
                "orderSentence": "Lamotrigine 25 mg PO daily"
              },
              {
                "text": "50 mg daily",
                "orderSentence": "Lamotrigine 50 mg PO daily"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Lamotrigine 100 mg PO daily"
              },
              {
                "text": "200 mg daily",
                "orderSentence": "Lamotrigine 200 mg PO daily"
              },
              {
                "text": "400 mg daily",
                "orderSentence": "Lamotrigine 400 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily x 2wk; then 50 mg daily x 2wk; titrate by 50 mg q2wk; max 400 mg/day",
            "orderSentence": "Lamotrigine 25 mg PO daily"
          },
          "contraindications": "History of severe rash with lamotrigine",
          "monitoring": "Rash (SJS risk); slow titration mandatory",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Valproic acid",
          "route": "PO",
          "indication": "Irritability; aggression; mood stabilization",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg BID",
                "orderSentence": "Valproic Acid 250 mg PO BID"
              },
              {
                "text": "500 mg BID",
                "orderSentence": "Valproic Acid 500 mg PO BID"
              },
              {
                "text": "750 mg BID",
                "orderSentence": "Valproic Acid 750 mg PO BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Valproic Acid 1000 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 250 mg BID; titrate to level 50-100 mcg/mL",
            "orderSentence": "Valproic Acid 250 mg PO BID"
          },
          "contraindications": "Hepatic disease; pregnancy (teratogenic); mitochondrial disease",
          "monitoring": "LFTs, ammonia, level, weight",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carbamazepine",
          "route": "PO",
          "indication": "Irritability; aggression; alternative mood stabilizer",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg BID",
                "orderSentence": "Carbamazepine 100 mg PO BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Carbamazepine 200 mg PO BID"
              },
              {
                "text": "400 mg BID",
                "orderSentence": "Carbamazepine 400 mg PO BID"
              },
              {
                "text": "600 mg BID",
                "orderSentence": "Carbamazepine 600 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg BID; titrate by 200 mg/wk; target level 4-12 mcg/mL",
            "orderSentence": "Carbamazepine 100 mg PO BID"
          },
          "contraindications": "AV block; blood dyscrasias; concurrent MAOIs",
          "monitoring": "CBC, LFTs, level, HLA-B*1502 in Asians",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Buspirone",
          "route": "PO",
          "indication": "Anxiety without sedation; adjunct for irritability",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Buspirone 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg TID; titrate by 5 mg q2-3d; max 60 mg/day",
            "orderSentence": "Buspirone 5 mg PO"
          },
          "contraindications": "Concurrent MAOIs",
          "monitoring": "None significant",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments - Cognitive and Other": [
        {
          "item": "Donepezil",
          "route": "PO",
          "indication": "Cognitive impairment; limited evidence in HD",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg daily",
                "orderSentence": "Donepezil 5 mg PO daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Donepezil 10 mg PO daily"
              },
              {
                "text": "23 mg daily",
                "orderSentence": "Donepezil 23 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg qHS; may increase to 10 mg after 4-6 weeks",
            "orderSentence": "Donepezil 5 mg PO daily"
          },
          "contraindications": "GI bleeding; sick sinus syndrome",
          "monitoring": "Nausea, bradycardia, diarrhea",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rivastigmine",
          "route": "PO/Patch",
          "indication": "Cognitive impairment; alternative to donepezil",
          "dosing": {
            "doseOptions": [
              {
                "text": "1.5 mg BID",
                "orderSentence": "Rivastigmine 1.5 mg PO/Patch BID"
              },
              {
                "text": "3 mg BID",
                "orderSentence": "Rivastigmine 3 mg PO/Patch BID"
              },
              {
                "text": "4.5 mg BID",
                "orderSentence": "Rivastigmine 4.5 mg PO/Patch BID"
              },
              {
                "text": "6 mg BID",
                "orderSentence": "Rivastigmine 6 mg PO/Patch BID"
              },
              {
                "text": "4.6 mg/24h daily",
                "orderSentence": "Rivastigmine 4.6 mg/24h PO/Patch daily"
              },
              {
                "text": "9.5 mg/24h daily",
                "orderSentence": "Rivastigmine 9.5 mg/24h PO/Patch daily"
              },
              {
                "text": "13.3 mg/24h daily",
                "orderSentence": "Rivastigmine 13.3 mg/24h PO/Patch daily"
              }
            ],
            "route": "PO/Patch",
            "instructions": "Start 1.5 mg BID or 4.6 mg patch; titrate monthly",
            "orderSentence": "Rivastigmine 1.5 mg PO/Patch BID"
          },
          "contraindications": "Severe hepatic impairment",
          "monitoring": "Nausea, weight loss",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Memantine",
          "route": "PO",
          "indication": "Moderate-severe cognitive impairment; neuroprotective theory",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg daily",
                "orderSentence": "Memantine 5 mg PO daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Memantine 10 mg PO daily"
              },
              {
                "text": "10 mg BID",
                "orderSentence": "Memantine 10 mg PO BID"
              },
              {
                "text": "28 mg daily ER",
                "orderSentence": "Memantine 28 mg PO daily ER"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
            "orderSentence": "Memantine 5 mg PO daily"
          },
          "contraindications": "Severe renal impairment (dose adjust)",
          "monitoring": "Confusion, constipation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Modafinil",
          "route": "PO",
          "indication": "Apathy; excessive daytime sleepiness",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Modafinil 100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg each morning; may increase to 200 mg; avoid afternoon dosing",
            "orderSentence": "Modafinil 100 mg PO"
          },
          "contraindications": "Arrhythmias; severe anxiety",
          "monitoring": "Insomnia, anxiety, BP",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Methylphenidate",
          "route": "PO",
          "indication": "Apathy; bradyphrenia; fatigue",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Methylphenidate 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg at breakfast and lunch; titrate by 5-10 mg q1wk; max 60 mg/day",
            "orderSentence": "Methylphenidate 5 mg PO"
          },
          "contraindications": "Severe anxiety; psychosis; cardiac arrhythmia",
          "monitoring": "HR, BP, appetite, insomnia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Trazodone",
          "route": "PO",
          "indication": "Insomnia; irritability; mild sedation",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg QHS",
                "orderSentence": "Trazodone 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Trazodone 50 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Trazodone 100 mg PO QHS"
              },
              {
                "text": "150 mg QHS",
                "orderSentence": "Trazodone 150 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg; max 200 mg for sleep",
            "orderSentence": "Trazodone 25 mg PO QHS"
          },
          "contraindications": "Concurrent MAOIs; priapism history",
          "monitoring": "Orthostatic hypotension, priapism",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Melatonin",
          "route": "PO",
          "indication": "Insomnia; circadian rhythm disturbance",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg QHS",
                "orderSentence": "Melatonin 1 mg PO QHS"
              },
              {
                "text": "3 mg QHS",
                "orderSentence": "Melatonin 3 mg PO QHS"
              },
              {
                "text": "5 mg QHS",
                "orderSentence": "Melatonin 5 mg PO QHS"
              },
              {
                "text": "10 mg QHS",
                "orderSentence": "Melatonin 10 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 3 mg 30 min before bed; may increase to 9 mg",
            "orderSentence": "Melatonin 1 mg PO QHS"
          },
          "contraindications": "None",
          "monitoring": "Generally well-tolerated",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Botulinum toxin (onabotulinumtoxinA)",
          "route": "IM",
          "indication": "Focal dystonia; bruxism; sialorrhea",
          "dosing": {
            "doseOptions": [
              {
                "text": "Variable per muscle",
                "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
              }
            ],
            "route": "IM",
            "instructions": "Dose depends on target muscles; repeat q12 weeks",
            "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
          },
          "contraindications": "Infection at site; myasthenia gravis",
          "monitoring": "Weakness, dysphagia",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Glycopyrrolate",
          "route": "PO",
          "indication": "Sialorrhea (drooling)",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg",
                "orderSentence": "Glycopyrrolate 1 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 1 mg BID; titrate to effect; max 2 mg TID",
            "orderSentence": "Glycopyrrolate 1 mg PO"
          },
          "contraindications": "Glaucoma; urinary retention; GI obstruction",
          "monitoring": "Dry mouth, constipation, urinary retention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Polyethylene glycol (MiraLAX)",
          "route": "PO",
          "indication": "Constipation (common with reduced mobility and anticholinergics)",
          "dosing": {
            "doseOptions": [
              {
                "text": "17 g",
                "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
              }
            ],
            "route": "PO",
            "instructions": "17 g in 8 oz liquid daily; may increase to BID",
            "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
          },
          "contraindications": "Bowel obstruction",
          "monitoring": "Diarrhea if excessive",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "High-calorie nutritional supplements",
          "route": "PO",
          "indication": "Weight loss; increased metabolic demands",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 can",
                "orderSentence": "High-calorie nutritional supplements 1 can PO"
              }
            ],
            "route": "PO",
            "instructions": "1-3 cans (Ensure Plus, Boost Plus) daily between meals",
            "orderSentence": "High-calorie nutritional supplements 1 can PO"
          },
          "contraindications": "None",
          "monitoring": "Weight, nutritional markers",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Huntington Disease Society of America (HDSA) Center of Excellence for comprehensive multidisciplinary care",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Genetic counselor for pre-test counseling, results disclosure, and family testing discussion",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Psychiatry for depression, suicidality assessment, irritability, and psychosis management",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neuropsychology for baseline and serial cognitive assessment to guide care planning",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Speech-language pathology for swallowing evaluation and communication strategies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for gait training, fall prevention, and adaptive exercise program",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for ADL adaptation, home safety evaluation, and energy conservation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Dietitian/nutritionist for weight maintenance strategies and caloric supplementation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for caregiver support, disability planning, and community resources",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Palliative care for symptom management, advance care planning, and goals of care discussions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pulmonology for respiratory assessment in advanced disease and ventilation decisions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gastroenterology for PEG tube placement consideration in advanced dysphagia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "CRITICAL: Report suicidal thoughts immediately as depression is common and treatable in HD",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive if experiencing significant chorea, cognitive impairment, or sedating medication effects",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Maintain high caloric intake (3000-4000 kcal/day may be needed) due to hypermetabolic state",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Eat slowly, take small bites, and remain upright 30 minutes after meals to reduce aspiration risk",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Complete advance directive and healthcare power of attorney while capacity is preserved",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Inform all healthcare providers about HD as many common medications can worsen symptoms",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "First-degree relatives have 50% risk; genetic counseling available but genetic testing is a personal choice",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid alcohol which worsens balance, cognition, and interacts with medications",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Regular aerobic exercise (walking, swimming, stationary bike) improves motor function and mood",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Maintain social engagement and meaningful activities to reduce depression and apathy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Cognitive engagement through puzzles, reading, and structured activities may help maintain function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Structure daily routine with consistent timing for medications, meals, and activities",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Caregiver respite and support groups essential to prevent caregiver burnout",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Smoking cessation to reduce aspiration pneumonia risk and cardiovascular disease",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Limit caffeine if insomnia or anxiety are problematic",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Huntington disease-like 1 (HDL1)",
      "features": "Prion protein gene mutation; similar phenotype",
      "tests": "PRNP gene testing"
    },
    {
      "diagnosis": "Huntington disease-like 2 (HDL2)",
      "features": "African ancestry; JPH3 gene mutation",
      "tests": "JPH3 gene testing"
    },
    {
      "diagnosis": "Spinocerebellar ataxia 17 (HDL4)",
      "features": "Prominent ataxia; TBP gene expansion",
      "tests": "TBP gene testing"
    },
    {
      "diagnosis": "Chorea-acanthocytosis",
      "features": "Orolingual dystonia; self-mutilation; acanthocytes",
      "tests": "Peripheral smear; VPS13A gene testing"
    },
    {
      "diagnosis": "McLeod syndrome",
      "features": "X-linked; cardiomyopathy; elevated CK",
      "tests": "Kell antigen typing; XK gene testing"
    },
    {
      "diagnosis": "Sydenham chorea",
      "features": "Post-streptococcal; younger patients; self-limited",
      "tests": "ASO titer; anti-DNAse B"
    },
    {
      "diagnosis": "Benign hereditary chorea",
      "features": "Childhood onset; non-progressive; NKX2-1 mutation",
      "tests": "NKX2-1 gene testing; family history"
    },
    {
      "diagnosis": "Wilson's disease",
      "features": "Younger onset; Kayser-Fleischer rings; hepatic disease",
      "tests": "Ceruloplasmin; 24-hr urine copper; slit lamp"
    },
    {
      "diagnosis": "Neuroacanthocytosis",
      "features": "Peripheral neuropathy; seizures; elevated CK",
      "tests": "Peripheral smear; genetic testing"
    },
    {
      "diagnosis": "Tardive dyskinesia",
      "features": "Antipsychotic exposure; orobuccal predominant",
      "tests": "Medication history; AIMS scale"
    },
    {
      "diagnosis": "Anti-NMDA receptor encephalitis",
      "features": "Psychiatric symptoms; seizures; dyskinesias",
      "tests": "NMDA receptor antibodies; CSF analysis"
    }
  ],
  "evidence": [
    {
      "recommendation": "Tetrabenazine reduces chorea in HD",
      "evidenceLevel": "Class I, Level A",
      "source": "[Huntington Study Group. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/16894067/)"
    },
    {
      "recommendation": "Deutetrabenazine reduces chorea with improved tolerability",
      "evidenceLevel": "Class I, Level A",
      "source": "[Huntington Study Group. JAMA 2016](https://pubmed.ncbi.nlm.nih.gov/27532915/)"
    },
    {
      "recommendation": "CAG repeat length inversely correlates with age of onset",
      "evidenceLevel": "Class II, Level B",
      "source": "[Andrew et al. Nat Genet 1993](https://pubmed.ncbi.nlm.nih.gov/8401589/)"
    },
    {
      "recommendation": "AAN practice parameter for HD treatment",
      "evidenceLevel": "Guideline",
      "source": "[Armstrong & Miyasaki. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22815556/)"
    },
    {
      "recommendation": "High suicide rate in HD requires screening",
      "evidenceLevel": "Class II, Level B",
      "source": "[Paulsen et al. J Neuropsychiatry Clin Neurosci 2005](https://pubmed.ncbi.nlm.nih.gov/16387989/)"
    },
    {
      "recommendation": "UHDRS reliable for tracking disease progression",
      "evidenceLevel": "Class II, Level A",
      "source": "[Huntington Study Group. Mov Disord 1996](https://pubmed.ncbi.nlm.nih.gov/8684382/)"
    },
    {
      "recommendation": "CYP2D6 genotype affects tetrabenazine metabolism",
      "evidenceLevel": "Class II, Level B",
      "source": "[Xenazine FDA prescribing information 2008](https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021894lbl.pdf)"
    },
    {
      "recommendation": "Genetic counseling improves outcomes in at-risk individuals",
      "evidenceLevel": "Class II, Level B",
      "source": "[Tibben. Handb Clin Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17352941/)"
    },
    {
      "recommendation": "Dysphagia common and associated with aspiration risk",
      "evidenceLevel": "Class II, Level C",
      "source": "[Heemskerk & Roos. Dysphagia 2011](https://pubmed.ncbi.nlm.nih.gov/20838817/)"
    },
    {
      "recommendation": "Multidisciplinary care improves outcomes",
      "evidenceLevel": "Class III, Level C",
      "source": "[Veenhuizen & Bherer. J Huntingtons Dis 2017](https://pubmed.ncbi.nlm.nih.gov/28287174/)"
    },
    {
      "recommendation": "Exercise benefits motor and cognitive function",
      "evidenceLevel": "Class II, Level B",
      "source": "[Quinn et al. Cochrane Database Syst Rev 2022](https://pubmed.ncbi.nlm.nih.gov/35994403/)"
    },
    {
      "recommendation": "Valbenazine effective for hyperkinetic movements",
      "evidenceLevel": "Class I, Level A",
      "source": "[Hauser et al. JAMA Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/29114728/)"
    }
  ],
  "monitoring": [
    {
      "item": "UHDRS (Unified Huntington's Disease Rating Scale)",
      "frequency": "Every 6-12 months",
      "action": "Adjust medications; update care plan",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Depression screening (PHQ-9)",
      "frequency": "Every visit; monthly if on VMAT2 inhibitor",
      "action": "Intensify antidepressant; psychiatry referral if PHQ-9 >15",
      "ED": "URGENT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Suicidality assessment",
      "frequency": "Every visit",
      "action": "Immediate psychiatric evaluation; safety planning",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Cognitive assessment (MoCA or MMSE)",
      "frequency": "Every 6-12 months",
      "action": "Update care planning; capacity assessment",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Weight",
      "frequency": "Every visit",
      "action": "Increase caloric intake; dietitian referral",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Swallowing function",
      "frequency": "Annually or if symptoms",
      "action": "Modify diet texture; speech therapy; PEG consideration",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ECG (if on VMAT2 inhibitor)",
      "frequency": "Baseline and with dose changes",
      "action": "Hold medication if QTc >500 ms; reduce dose",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Functional independence (TFC)",
      "frequency": "Every 6-12 months",
      "action": "Adjust level of care; advance care planning",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Caregiver burden assessment",
      "frequency": "Annually",
      "action": "Respite care; support resources",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Falls frequency",
      "frequency": "Each visit",
      "action": "PT referral; home safety; medication review",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Stable psychiatric status; adequate oral intake; safe swallowing; caregiver available; outpatient follow-up arranged"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Severe psychiatric symptoms requiring stabilization; aspiration pneumonia; significant weight loss requiring evaluation; severe chorea causing exhaustion or injury"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Aspiration with respiratory failure; severe rhabdomyolysis from chorea; neuroleptic malignant syndrome; suicidal attempt requiring medical stabilization"
    },
    {
      "disposition": "Skilled nursing facility",
      "criteria": "Advanced disease; 24-hour care needs; dysphagia requiring supervision; frequent falls; caregiver unable to provide required care"
    },
    {
      "disposition": "Hospice referral",
      "criteria": "End-stage disease (TFC stage 5); recurrent aspiration; patient/family goals favor comfort care"
    }
  ]
}
